Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by palinc2000on Aug 02, 2022 6:29pm
113 Views
Post# 34866884

RE:RE:RE:Fireside Chat on August 10

RE:RE:RE:Fireside Chat on August 10

Ok so it was the company 's timelines.... Where did the company get the original timeline? From Paul ?
I doubt that ! The problem with your friend is that he originally said that the reason scientists were not sold on TH1902 was that it was too simple and not complexed enough ....and he also was hoping for miraculous results just a few months after the initiation of Phase 1 a....That was HIS timeline.
Of course he never accepts being wrong and his need to blame others takes over...
We all remember the calls for Christian to wake up and the same to Paul and he still blames the company for a flawed Phase 1 trial design

You are now also implyimg that the Company was somehow incompetent in predicting the time lines for Phase 1 a .... Why are you voting the shares you control for such dumb management?
P,S 
My previous post was written on a sandy beach with a glaring sun in between swims in the beautiful ocean with dirty sun glasses .... I did not think that spelling errors bothered you.... I will not post on sunny days outside any more

SPCEO1 wrote: Some thoughts on your comments:

1.) The timelines the company originally gave were way off the mark for 1a. That is just a fact and the company did not do a very good job of updating the market in a timely manner about the delays.

2.) The whole point of a phase 1a dose escalation trial is to push the dosage levels up to the point where you have side-effects. So, that is the plan from the get go - find just how far you can push it. Also, mice cannot talk, so they have a hard time reporting on some side-effects! 

3.)  I don't think we really know what delayed the phase 1a. Since the goal is to find a dose that causes problems and then step back to a lower dose, that should not have caused any delay. Maybe one day we will know what caused the delay but my best guess is a debate about whether the problems at the 420mg level were big enough and constant enough across patients to stop there.

4.) Not that I have any standing on this subject, but your spelling really falls apart when you reply to JFM, reflecting your long term animosity for him getting the best of you. He made a simple and factual point about the really bad predictions Paul made about the time it would take to complete the phase 1a and you responded with a whole bunch of other heated, mis-spelled stuff. 

As Rodney King once famously asked in the midst of rioting in Los Angeles - "Can't we all just get along?"   

 

<< Previous
Bullboard Posts
Next >>